Pharmac Opens Consultation on New Cancer Medicines after $604M Funding Boost

“As a result of the coalition Government’s $604 million funding boost, consultation is able to start today for the first two targeted cancer treatments,” said Seymour.

Associate Health Minister for Pharmac David Seymour has announced that Pharmac is opening consultation on new cancer medicines, marking a significant development for Kiwi cancer patients and their families.

“As a result of the coalition Government’s $604 million funding boost, consultation is able to start today for the first two targeted cancer treatments,” said Seymour.

“More funding for cancer medicines means more choices and options available to Pharmac.”

On June 24, the Government announced it would deliver the funding boost to enable Pharmac to use its bargaining power to procure more medicines. Seymour expressed his delight that the process is already underway, praising Pharmac for its swift action.

“It is important to note that Pharmac’s model is independent and designed to get the best value for New Zealanders in procuring these medicines, while the Government’s job is to make sure the right regulatory settings are in place and the funding is there for Pharmac. Ensuring that independence is very important to me,” Seymour emphasized.

The consultation for this first tranche is open until Friday, July 26. Following this period, a funding proposal will be taken to Pharmac’s Board for a decision.

“For many New Zealanders, funding for pharmaceuticals is life or death, or the difference between a life of pain and suffering or living freely. New cancer medicines will make a significant difference to people’s lives by slowing the progression of their cancer,” Seymour concluded.